📋FHFA Proposes Rescindment of Applicant Tracking System SORN
In accordance with the requirements of the Privacy Act of 1974, as amended, (Privacy Act), and Office of Management Budget (OMB) Circular No. A-108, "Federal Agency Responsibilities for Review, Reporting, and Publication under the Privacy Act," the Federal Housing Finance Agency (FHFA or Agency) proposes to rescind an existing System of Records Notice (SORN). The SORN being rescinded is based on a third- party operated system of records that is no longer maintained by the Agency and has been decommissioned. FHFA-25, Applicant Tracking System was used by FHFA to post and publicize mission critical occupation job openings using FHFA's authority to hire examiners, accountants, economists, and specialists in financial markets and in technology; receive, store, and process resumes, applications, curriculum vitaes, and similar documents received in response to mission critical occupation job openings and recruiting and outreach events; and track applicants for such positions.
Learn More🏺Inventory Completion Notice – Louisiana State University Museum
In accordance with the Native American Graves Protection and Repatriation Act (NAGPRA), the Louisiana State University, Museum of Natural Science (LSUMNS) has completed an inventory of human remains and has determined that there is a cultural affiliation between the human remains and Indian Tribes or Native Hawaiian organizations in this notice.
Learn More💉FDA's Regulatory Review Period Determination for AVEIR VR System
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for AVEIR VR Leadless System and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that medical device.
Learn More🌳Antidumping Duty Review on Wood Products from China
The U.S. Department of Commerce (Commerce) preliminarily determines that exporters subject to this review made sales of subject merchandise at less than normal value during the period of review (POR), February 1, 2023, through January 31, 2024. Further, Commerce is also rescinding this review with respect to 20 of the 38 companies/ company groupings under review. Interested parties are invited to comment on these preliminary results of review.
Learn More🌱EPA Updates Chlorpyrifos Cancellation Order for Asparagus Use
On June 24, 2024, the Environmental Protection Agency (EPA or the Agency) issued a final cancellation order pursuant to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) terminating several food uses on registered chlorpyrifos products, the majority of which were voluntarily requested by Gharda Chemicals International, Inc. (Gharda) and accepted by the Agency. Upon further review of that order, EPA identified an error, which it is correcting in this document. Specifically, EPA is rescinding the termination of asparagus use in the state of Michigan for Pilot 4E Chlorpyrifos Agricultural Insecticide, EPA Reg. No. 93182-7, as Gharda did not request termination of that use.
Learn More📊OMB Review Notice on Cost Accounting Standards Administration
Under the provisions of the Paperwork Reduction Act, the Regulatory Secretariat Division has submitted to OMB a request to review and approve an extension of a previously approved information collection requirement regarding cost accounting standards administration.
Learn More💡Licensing Opportunities for Government-Owned Influenza Inventions
The invention listed below is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
Learn More💊FDA Notice on BRIUMVI Patent Extension Implications
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for BRIUMVI and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human biological product.
Learn More📈Cboe Rule Change to Extend Trading Hours for Expiring Options
The SEC approved a rule change by Cboe Exchange to allow certain A.M.-settled index options to trade during Global Trading Hours leading to their expiration. This modification aims to enhance risk management for market participants, providing more trading opportunities right before settlement and aligning with global market dynamics.
Learn More🏦Change in Bank Control Notices
The Federal Reserve System has issued notice regarding applications for acquiring shares of banks or bank holding companies under the Change in Bank Control Act. Interested parties can comment on these applications, with disclosures on public comments. The document highlights the regulatory framework guiding bank control changes, ensuring transparency in acquisitions.
Learn More